Diabetes
What is Diabetes?
Read More
Latest Updates on Diabetes
Hit the gym! Building muscles may cut diabetes risk by 44%, genes no bar
Muscle up, sugar down: A new study has found individuals with high muscle strength have a 44% lower risk of developing type 2 diabetes, irrespective of their genetic predisposition to the disease
Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know
Glenmark launches Empagliflozin for diabetes in India under Glempa brand
The medications are designed to improve glycemic control in adults with type 2 diabetes mellitus while also reducing cardiovascular outcomes in patients with cardiovascular risk
Biocon launches drug Liraglutide for diabetes, Biolide for obesity in UK
Launch comes after approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, earlier this year, making Biocon the first generics company to obtain approval for gLiraglutide
Asian healthcare market to touch $5 trillion by 2030, says BCG report
The pharmaceutical and MedTech sectors are also expected to see significant growth of 9 per cent and 8 per cent, respectively, over the next five years
Lupin acquires Huminsulin from Lilly to strengthen diabetes portfolio
The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and children
88 mn women screened for cervical cancer under national programme: Govt
Under the same programme, over 14 crore were screened for breast cancer and more than 26 crore for oral cancer
ICMR sets up India's first diabetes biobank in Chennai for research
Biobanks are critical in biomedical research, collecting, processing, storing and distributing biospecimens to support scientific research, the article said
India's health at a sugar tipping point, 50% see glucose imbalance
According to a report by diagnostic service provider Thyrocare, 49.43 per cent of the tested population in India exhibited abnormal blood glucose levels
Biocon Biologics, Diabetes Africa collab over nurses project in Ethiopia
Ethiopia, with a 2-3 per cent diabetes prevalence rate, ranks among the top four countries in sub-Saharan Africa for adult diabetes cases
Zerodha CEO Nithin Kamath sounds alarm on India's diabetes crisis
Kamath revealed that a 20-year-old woman living in a city today has a 64.6 per cent chance of developing diabetes in her lifetime, while for young men, the risk is 55.5 per cent
Over 800 million adults have diabetes globally, many untreated: Study
In 2022, there were around 828 million people aged 18 years and older with type 1 and type 2 diabetes worldwide, the study found
World Diabetes Day 2024: Theme, history and best winter foods for patients
Every year on November 14, we observe the World Diabetes Day (WDD) to increase awareness of diabetes, a chronic condition that affects millions of people worldwide
Wockhardt gains 4% on filing for DCGI's approval for its insulin injection
Wockhardt is also developing additional insulin analogs and GLP-1 agonists to provide advanced diabetes care solutions
How fried and processed foods are fuelling India's diabetes epidemic
Indian diets, traditionally rich in whole grains, fruits, and vegetables, have shifted towards processed, fried, and sugar-laden foods, according to a recent government-backed study
Glucose Tolerance Test: Here's why and when your doctor recommends it
The glucose tolerance test measures how the body reacts to sugar or glucose and is frequently used to detect insulin resistance and type 2 diabetes or prediabetes
Breakthrough stem-cell transplant in China offers hope for Type 1 diabetes
Adipose tissue cells from the patient were reprogrammed into stem cells, converted to islet cells, and transplanted back, eliminating the risk of immune rejection as they were from her own body
Chinese scientists reverse type 1 diabetes with cell transplant: Report
Now, stem cell therapy has opened up new possibilities for diabetes treatment, the report said
Late-night sleepers face 50% greater risk of developing Type 2 diabetes
Staying up late increases Type 2 diabetes risk by nearly 50 per cent and is associated with higher BMI, larger waist circumference, and more visceral and liver fat
No suicidal thoughts link to diabetes, obesity drugs, finds UK regulator
The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists, more than a year ago
